Real-time enrollment status for this tma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 9:58 AM UTC
| NCT Number | NCT05855083 |
| Recruiting Status | Recruiting |
| Condition | TMA |
| Phase | PHASE2 |
| Target Enrollment | 18 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Omeros Corporation |
| Last Updated on CT.gov | March 25, 2025 (Mar 25, 2025) |
As of August 28, 2026: Clinical trial NCT05855083 is currently recruiting participants. This phase2 study for tma is actively seeking new participants at 8 locations across the United States. The study is sponsored by Omeros Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05855083 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05855083 was last updated Mar 25, 2025 (March 25, 2025). HelloStudys verifies this status automatically.